COAPT™ Trial Results Demonstrate Long-Term Benefits of Abbott’s MitraClip™ Device
for Heart Failure Patients Recent findings from the COAPT™ clinical trial have demonstrated the long-term benefits of Abbott's MitraClip™ device for heart failure patients. The trial, which was conducted by the Cardiovascular Research Foundation, showed that the MitraClip™ device significantly reduced hospitalizations and improved quality of life for patients with heart failure. The MitraClip™ device is a minimally invasive device that is used to treat mitral regurgitation, a condition in which the mitral valve does not close properly and allows blood to flow backward in the heart. The device works